<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">39557887</PMID><DateCompleted><Year>2024</Year><Month>11</Month><Day>18</Day></DateCompleted><DateRevised><Year>2024</Year><Month>11</Month><Day>18</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2045-2322</ISSN><JournalIssue CitedMedium="Internet"><Volume>14</Volume><Issue>1</Issue><PubDate><Year>2024</Year><Month>Nov</Month><Day>18</Day></PubDate></JournalIssue><Title>Scientific reports</Title><ISOAbbreviation>Sci Rep</ISOAbbreviation></Journal><ArticleTitle>Predictive risk models for COVID-19 patients using the multi-thresholding meta-algorithm.</ArticleTitle><Pagination><StartPage>28453</StartPage><MedlinePgn>28453</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1038/s41598-024-77386-7</ELocationID><Abstract><AbstractText>This study aims to develop a Machine Learning model to assess the risks faced by COVID-19 patients in a hospital setting, focusing specifically on predicting the complications leading to Intensive Care Unit (ICU) admission or mortality, which are minority classes compared to the majority class of discharged patients. We operate within a multiclass framework comprising three distinct classes, and address the challenge of dataset imbalance, a common source of model bias. To effectively manage this, we introduce the Multi-Thresholding meta-algorithm (MTh), an innovative output-level methodology that extends traditional thresholding from binary to multiclass classification. This methodology dynamically adjusts class probabilities using misclassification costs, making it highly effective in imbalanced datasets. Our approach is further enhanced by integrating the simplicity, transparency, and effectiveness of Bayesian networks to create a robust predictive model. Using patient admission data, the model accurately identifies key risk and protective factors for COVID-19 outcomes. Our findings indicate that certain patient characteristics, such as high Charlson Index and pre-existing conditions, significantly influence the risk of ICU admission and mortality. Moreover, we introduce an explanatory model that elucidates the interrelationships among these factors, demonstrating the influence of therapeutic limits on the overall risk assessment of COVID-19 patients. Overall, our research provides a significant contribution to the field of Machine Learning by offering a novel solution for multiclass classification in the context of imbalanced datasets. This model not only enhances predictive accuracy but also supports critical decision-making processes in healthcare, potentially improving patient outcomes and optimizing clinical resource allocation.</AbstractText><CopyrightInformation>© 2024. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Delgado</LastName><ForeName>Rosario</ForeName><Initials>R</Initials><Identifier Source="ORCID">0000-0003-1208-9236</Identifier><AffiliationInfo><Affiliation>Department of Mathematics, Universitat Autònoma de Barcelona, Barcelona, Spain. Rosario.Delgado@uab.cat.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fernández-Peláez</LastName><ForeName>Francisco</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Applied Artificial Intelligence Unit, Eurecat, Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pallarés</LastName><ForeName>Natàlia</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Biostatistics Unit of the Bellvitge Biomedical Research Institute (IDIBELL), Barcelona, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Basic Clinical Practice, School of Medicine and Health Sciences, University of Barcelona, Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Diaz-Brito</LastName><ForeName>Vicens</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Department of Infectious Diseases, Parc Sanitari S. Joan de Deu, Sant Boi de Llobregat, Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Izquierdo</LastName><ForeName>Elisenda</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Anaesthesiology, Viladecans Hospital, Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Oriol</LastName><ForeName>Isabel</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Department of Clinical Sciences, School of Medicine and Health Sciences, University of Barcelona, Barcelona, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Bellvitge Biomedical Research Institute, Barcelona, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Unitat Malalties Infeccioses, Servei Medicina Interna, Consorci Sanitari Integral, Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Simonetti</LastName><ForeName>Antonella</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Àrea de Recerca, Consorci Sanitari Alt Penedès Garraf, Barcelona, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>CIBERINFEC, Instituto de Salud Carlos III, Sevilla, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Infectious Disease Unit, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tebé</LastName><ForeName>Cristian</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Biostatistics Unit of the Bellvitge Biomedical Research Institute (IDIBELL), Barcelona, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Clinical Sciences, School of Medicine and Health Sciences, University of Barcelona, Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Videla</LastName><ForeName>Sebastià</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Clinical Pharmacology, Bellvitge University Hospital, Barcelona, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pathology and Exp. Therapeutics, School Medicine and Health Sci., University of Barcelona, Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Carratalà</LastName><ForeName>Jordi</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Clinical Sciences, School of Medicine and Health Sciences, University of Barcelona, Barcelona, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Bellvitge Biomedical Research Institute, Barcelona, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Infetious Diseases, Bellvitge University Hospital, Barcelona, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>CIBERINFEC, Instituto de Salud Carlos III, Sevilla, Spain.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>PID2021-123733NB-I00</GrantID><Agency>Ministerio de Ciencia e Innovación</Agency><Country /></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>11</Month><Day>18</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Sci Rep</MedlineTA><NlmUniqueID>101563288</NlmUniqueID><ISSNLinking>2045-2322</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007362" MajorTopicYN="Y">Intensive Care Units</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000069550" MajorTopicYN="Y">Machine Learning</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000465" MajorTopicYN="Y">Algorithms</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018570" MajorTopicYN="N">Risk Assessment</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001499" MajorTopicYN="Y">Bayes Theorem</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName><QualifierName UI="Q000302" MajorTopicYN="N">isolation &amp; purification</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006760" MajorTopicYN="N">Hospitalization</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Bayesian Networks</Keyword><Keyword MajorTopicYN="N">COVID-19 patient risks assessment</Keyword><Keyword MajorTopicYN="N">Cost-sensitive Machine Learning modelling</Keyword><Keyword MajorTopicYN="N">Healthcare decision-making</Keyword><Keyword MajorTopicYN="N">Multiclass classification thresholding</Keyword></KeywordList><CoiStatement><b>Declarations</b> <b>Conflict of interest</b> The authors declare no potential conflict of interests nor competing interests.github.com/RosDelgado/MTh <b>Code availability</b> The computer programming code (R function) that has been developed and utilized in this study, to implement Algorithm 1 (the Multi-Thresholding meta-algorithm, MTh) is accessible under an open-access (MIT) license. You can find it at https://github.com/RosDelgado/MTh. <b>Ethical implications</b> The use of predictive models in clinical settings raises several important ethical considerations. First and foremost, privacy and data security are critical: patient data used for training and validating models must be protected, and all practices must comply with data protection regulations. Second, it is essential to address potential biases within the model to ensure that predictions are equitable across different patient groups and to prevent discrimination in care. Third, predictive models should be used to complement, rather than replace, clinical judgment. It is important to be transparent about the limitations and uncertainties inherent in the model’s predictions. Lastly, patients should be adequately informed about the use of predictive models in their care. Clear communication is necessary to help patients to understand how these models influence clinical decisions.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>2</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>10</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>11</Month><Day>19</Day><Hour>0</Hour><Minute>23</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>11</Month><Day>19</Day><Hour>0</Hour><Minute>22</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>11</Month><Day>18</Day><Hour>23</Hour><Minute>29</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39557887</ArticleId><ArticleId IdType="doi">10.1038/s41598-024-77386-7</ArticleId><ArticleId IdType="pii">10.1038/s41598-024-77386-7</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Li, Q. et al. Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus-Infected Pneumonia. N Engl J Med. 382(13), 1199–1207. https://doi.org/10.1056/NEJMoa2001316 (2020).</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2001316</ArticleId><ArticleId IdType="pubmed">31995857</ArticleId><ArticleId IdType="pmc">7121484</ArticleId></ArticleIdList></Reference><Reference><Citation>Pallarès, N. et al. Characteristics and Outcomes by Ceiling of Care of Subjects Hospitalized with COVID-19 During Four Waves of the Pandemic in a Metropolitan Area: A Multicenter Cohort Study. Infect Dis Ther. 12(1), 273–289. https://doi.org/10.1007/s40121-022-00705-w (2023).</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40121-022-00705-w</ArticleId><ArticleId IdType="pubmed">36495405</ArticleId></ArticleIdList></Reference><Reference><Citation>Cester, A., Maselli, M. &amp; Bolzetta, F. How to define the therapeutic limits. Monaldi Arch Chest Dis. 87(2), 846. https://doi.org/10.4081/monaldi.2017.846 (2017).</Citation><ArticleIdList><ArticleId IdType="doi">10.4081/monaldi.2017.846</ArticleId><ArticleId IdType="pubmed">28967726</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang, A. Z. et al. Can we predict which COVID-19 patients will need transfer to intensive care within 24 hours of floor admission?. Acad Emerg Med. 28(5), 511–518. https://doi.org/10.1111/acem.14245 (2021).</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/acem.14245</ArticleId><ArticleId IdType="pubmed">33675164</ArticleId><ArticleId IdType="pmc">8251424</ArticleId></ArticleIdList></Reference><Reference><Citation>Zietz, M., Zucker, J. &amp; Tatonetti, N. P. Associations between blood type and COVID-19 infection, intubation, and death. Nat Commun. 11(1), 5761. https://doi.org/10.1038/s41467-020-19623-x (2020).</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-020-19623-x</ArticleId><ArticleId IdType="pubmed">33188185</ArticleId><ArticleId IdType="pmc">7666188</ArticleId></ArticleIdList></Reference><Reference><Citation>López-Otero, D. et al. Asociación entre el daño miocárdico y el pronóstico de pacientes hospitalizados por COVID-19, con y sin cardiopatía (in Spanish). Registro CARDIOVID. Rev Esp Cardiol. 74(1), 105–108. https://doi.org/10.1016/j.recesp.2020.08.003 (2021).</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.recesp.2020.08.003</ArticleId><ArticleId IdType="pubmed">32958975</ArticleId></ArticleIdList></Reference><Reference><Citation>Berenguer, J. et al. Development and validation of a prediction model for 30-day mortality in hospitalised patients with COVID-19: the COVID-19 SEIMC score. Thorax 76(9), 920–929. https://doi.org/10.1136/thoraxjnl-2020-216001 (2021).</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/thoraxjnl-2020-216001</ArticleId><ArticleId IdType="pubmed">33632764</ArticleId></ArticleIdList></Reference><Reference><Citation>Berenguer, J. et al. Characteristics and predictors of death among 4035 consecutively hospitalized patients with COVID-19 in Spain. Clinical Microbiology and Infection 26(11), 1525–1536. https://doi.org/10.1016/j.cmi.2020.07.024 (2020).</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmi.2020.07.024</ArticleId><ArticleId IdType="pubmed">32758659</ArticleId><ArticleId IdType="pmc">7399713</ArticleId></ArticleIdList></Reference><Reference><Citation>Lovejoy, C. A., Buch, V. &amp; Maruthappu, M. Artificial intelligence in the intensive care unit. Crit Care 23, 7. https://doi.org/10.1186/s13054-018-2301-9 (2019).</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13054-018-2301-9</ArticleId><ArticleId IdType="pubmed">30630492</ArticleId><ArticleId IdType="pmc">6327423</ArticleId></ArticleIdList></Reference><Reference><Citation>Chicco, D. &amp; Jurman, G. Machine learning can predict survival of patients with heart failure from serum creatinine and ejection fraction alone. BMC Med Inform Decis Mak. 20, 16. https://doi.org/10.1186/s12911-020-1023-5 (2020).</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12911-020-1023-5</ArticleId><ArticleId IdType="pubmed">32013925</ArticleId><ArticleId IdType="pmc">6998201</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang, L., Lin, Z. Q. &amp; Wong, A. COVID-Net: a tailored deep convolutional neural network design for detection of COVID-19 cases from chest X-ray images. Sci Rep 10, 19549. https://doi.org/10.1038/s41598-020-76550-z (2020).</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-020-76550-z</ArticleId><ArticleId IdType="pubmed">33177550</ArticleId><ArticleId IdType="pmc">7658227</ArticleId></ArticleIdList></Reference><Reference><Citation>Dalal, S., Singh, J. P., Tiwari, A. K. &amp; Kumar, A. Identification of COVID-19 with CT scans using radiomics and DL-based features. Netw Model Anal Health Inform Bioinforma 13(14). https://doi.org/10.1007/s13721-024-00448-3 (2024).</Citation></Reference><Reference><Citation>Ben-Gal, I. Bayesian Networks. In Encyclopedia of Statistics in Quality and Reliability (eds F. Ruggeri, R.S. Kenett &amp; F.W. Faltin) (2008) https://doi.org/10.1002/9780470061572.eqr089</Citation></Reference><Reference><Citation>Neil, M., Fenton, N. &amp; Tailor, M. Using Bayesian Networks to Model Expected and Unexpected Operational Losses. Risk Anal. 25(4), 963–972. https://doi.org/10.1111/j.1539-6924.2005.00641.x (2005).</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1539-6924.2005.00641.x</ArticleId><ArticleId IdType="pubmed">16268944</ArticleId></ArticleIdList></Reference><Reference><Citation>Delgado, R., González, J.L., Sotoca, A., &amp; Tibau, X.A. A Bayesian Network Profiler for Wildfire Arsonists. In: Pardalos, P., Conca, P., Giuffrida, G., Nicosia, G. (eds) Machine Learning, Optimization, and Big Data. MOD 2016. Lecture Notes in Computer Science 10122. Springer, Cham. (2016) https://doi.org/10.1007/978-3-319-51469-7_31</Citation></Reference><Reference><Citation>Delgado, R. &amp; Sánchez-Delgado, H. Multi-instance learning with application to the profiling of multi-victim homicides. Expert Systems with Applications 237, Part B, 121593. https://doi.org/10.1016/j.eswa.2023.121593 (2024).</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eswa.2023.121593</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao, D. &amp; Weng, C. Combining PubMed knowledge and EHR data to develop a weighted bayesian network for pancreatic cancer prediction. J Biomed Inform 44(5), 859–868. https://doi.org/10.1016/j.jbi.2011.05.004 (2011).</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jbi.2011.05.004</ArticleId><ArticleId IdType="pubmed">21642013</ArticleId><ArticleId IdType="pmc">3174321</ArticleId></ArticleIdList></Reference><Reference><Citation>Delgado, R., Núñez-González, J.D., Yébenes, J.C., &amp; Lavado, A. Vital Prognosis of Patients in Intensive Care Units Using an Ensemble of Bayesian Classifiers. In: Nicosia, G., Pardalos, P., Umeton, R., Giuffrida, G., Sciacca, V. (eds) Machine Learning, Optimization, and Data Science. LOD 2019. Lecture Notes in Computer Science 11943. Springer, Cham. (2019) https://doi.org/10.1007/978-3-030-37599-7_51</Citation></Reference><Reference><Citation>Delgado, R., Núñez-González, J. D., Yébenes, J. C. &amp; Lavado, A. Survival in the Intensive Care Unit: A prognosis model based on Bayesian classifiers. Artificial Intelligence in Medicine 115, 102054. https://doi.org/10.1016/j.artmed.2021.102054 (2021).</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.artmed.2021.102054</ArticleId><ArticleId IdType="pubmed">34001314</ArticleId></ArticleIdList></Reference><Reference><Citation>McLachlan, S. et al. The fundamental limitations of COVID-19 contact tracing methods and how to resolve them with a Bayesian network approach. Preprint (2020) https://doi.org/10.13140/RG.2.2.27042.66243</Citation></Reference><Reference><Citation>Osarumwense, A.S., &amp; Osayamen, O.K. A CoronaVirus Disease-2019 Prediction Model Based on Bayesian Belief Network. International Journal of Academic Engineering Research (IJAER) 4(4), 24–35 (2020) http://ijeais.org/wp-content/uploads/2020/4/IJAER200404.pdf</Citation></Reference><Reference><Citation>Fenton, N. A Note on UK Covid19 death rates by religion: which groups are most “at risk”? Preprint (2020) https://doi.org/10.48550/arXiv.2007.07083</Citation></Reference><Reference><Citation>Avila, E., Kahmann, A., Alho, C. &amp; Dorn, M. Hemogram data as a tool for decision-making in COVID-19 management: applications to resource scarcity scenarios. PeerJ. 8, e9482. https://doi.org/10.7717/peerj.9482 (2020).</Citation><ArticleIdList><ArticleId IdType="doi">10.7717/peerj.9482</ArticleId><ArticleId IdType="pubmed">32656001</ArticleId><ArticleId IdType="pmc">7331623</ArticleId></ArticleIdList></Reference><Reference><Citation>Jian, C. et al. A pattern categorization of CT findings to predict outcome of COVID-19 pneumonia. Front Public Health. 8, 567672. https://doi.org/10.3389/fpubh.2020.567672 (2020).</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fpubh.2020.567672</ArticleId><ArticleId IdType="pubmed">33072703</ArticleId><ArticleId IdType="pmc">7531052</ArticleId></ArticleIdList></Reference><Reference><Citation>Abe, N., Zadrozny, B., &amp; Langford, J. An Iterative Method for Multiclass Cost-Sensitive Learning. Proc. 10th ACM SIGKDD Intl Conf. Knowledge Discovery and Data Mining, 3–11 (2004) https://dl.acm.org/doi/pdf/10.1145/1014052.1014056</Citation></Reference><Reference><Citation>Zhou, Z. H. &amp; Liu, X. Y. On multi-class cost-sensitive learning. Computational Intelligence 26, 232–257. https://doi.org/10.1111/j.1467-8640.2010.00358.x (2010).</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1467-8640.2010.00358.x</ArticleId></ArticleIdList></Reference><Reference><Citation>Elkan, C. The Foundations of Cost-Sensitive Learning. In Proceedings of the 17th International Joint Conference of Artificial Intelligence (IJCAI’01) 2, 973–978. Seattle, Washington: Morgan Kaufmann (2001) https://dl.acm.org/doi/10.5555/1642194.1642224</Citation></Reference><Reference><Citation>Zadrozny, B., &amp; Elkan, C. Learning and Making Decisions When Costs and Probabilities are Both Unknown. In Proceedings of the seventh ACM SIGKDD international conference on Knowledge discovery and data mining, 204–213 (2001) https://doi.org/10.1145/502512.502540</Citation></Reference><Reference><Citation>Chawla, N. V., Bowyer, K. W., Hall, L. O. &amp; Kegelmeyer, W. P. SMOTE: Synthetic Minority Over-sampling Technique. Journal of Artificial Intelligence Research 16(1), 321–357. https://doi.org/10.5555/1622407.1622416 (2002).</Citation><ArticleIdList><ArticleId IdType="doi">10.5555/1622407.1622416</ArticleId></ArticleIdList></Reference><Reference><Citation>Zeng, M., Zou, B., Wei, F., Liu, X., &amp; Wang, L. Effective prediction on three common diseases by combining SMOTE with Tomek links technique for imbalanced medical data. In: 2016 IEEE International Conference of Online Analysis and Computing Sciences (ICOACS), Chongqing, China, 225–228 (2016) https://doi.org/10.1109/ICOACS.2016.7563084</Citation></Reference><Reference><Citation>Xu, Z., Shen, D., Nie, T. &amp; Kou, Y. A hybrid sampling combining M-SMOTE and ENN based on Random forest for medical imbalanced data. J. Biomed. Inf. 107, 103465. https://doi.org/10.1016/j.jbi.2020.103465 (2020).</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jbi.2020.103465</ArticleId></ArticleIdList></Reference><Reference><Citation>Shilaskar, S., Ghatol, A. &amp; Chatur, P. Medical decision support systems for extremely imbalanced datasets. Inf. Sci. 384, 205–219. https://doi.org/10.1016/j.ins.2016.08.077 (2017).</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ins.2016.08.077</ArticleId></ArticleIdList></Reference><Reference><Citation>Delgado, R. &amp; Núñez-González, J. D. Bayesian network-based Over-Sampling MEthod (BOSME) with application to indirect cost-sensitive learning. Sci Rep. 12, 8724. https://doi.org/10.1038/s41598-022-12682-8 (2022).</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-022-12682-8</ArticleId><ArticleId IdType="pubmed">35610323</ArticleId><ArticleId IdType="pmc">9130330</ArticleId></ArticleIdList></Reference><Reference><Citation>Lomax, S. &amp; Vadera, S. A cost-sensitive decision tree learning algorithm based on multi-armed bandit framework. The Computer Journal 60(7), 941–956. https://doi.org/10.1093/comjnl/bxw015 (2017).</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/comjnl/bxw015</ArticleId></ArticleIdList></Reference><Reference><Citation>Ali, S. I. et al. Ensemble feature ranking for cost-based non-overlapping groups: a case study of chronic kidney disease diagnosis in developing countries. In IEEE Acces 8, 215623–215648. https://doi.org/10.1109/ACCESS.2020.3040650 (2020).</Citation><ArticleIdList><ArticleId IdType="doi">10.1109/ACCESS.2020.3040650</ArticleId></ArticleIdList></Reference><Reference><Citation>Phankokkruad, M. Cost-sensitive extreme gradient boosting for imbalanced classification of breast cancer diagnosis. In 10th IEEE International Conference on Control System, Computing and Engineering (ICCSCE), Penang, Malaysia, 46–51 (2020) https://doi.org/10.1109/ICCSCE50387.2020.9204948</Citation></Reference><Reference><Citation>Mienye, I. D. &amp; Sun, Y. Performance analysis of cost-sensitive learning methods with application to imbalanced medical data. Informatics in Medicine Unlocked 25, 100690. https://doi.org/10.1016/j.imu.2021.100690 (2021).</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.imu.2021.100690</ArticleId></ArticleIdList></Reference><Reference><Citation>Domingos, P. MetaCost: A general method for making classifiers cost-sensitive. In Proceedings of the fifth ACM SIGKDD International Conference on Knowledge Discovery and Data Mining (KDD’99). Association for Computing Machinery, New York, NY, USA, 155–164 (1999) https://doi.org/10.1145/312129.312220</Citation></Reference><Reference><Citation>Witten, I. H. &amp; Frank, E. Data Mining - Practical Machine Learning Tools and Techniques with Java Implementations (Morgan Kaufmann Publishers, 2005).</Citation></Reference><Reference><Citation>Xiaoyong, C., Deng, L., Yang, Q., &amp; Ling, C.X. Test-Cost Sensitive Naïve Bayesian Classification. In Proceedings of the Fourth IEEE International Conference on Data Mining (ICDM’04). Brighton, UK: IEEE Computer Society Press, 51–58 (2004) https://ieeexplore.ieee.org/document/1410266</Citation></Reference><Reference><Citation>Charlson, M., Szatrowski, T. P., Peterson, J. &amp; Gold, J. Validation of a combined comorbidity index. J. Clin. Epidemiol. 47(11), 1245–1251. https://doi.org/10.1016/0895-4356(94)90129-5 (1994).</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0895-4356(94)90129-5</ArticleId><ArticleId IdType="pubmed">7722560</ArticleId></ArticleIdList></Reference><Reference><Citation>Hruschka, E.R., Hruschka, E.R., &amp; Ebecken, N.F.F. Feature Selection by Bayesian Networks. In: Tawfik, A.Y., Goodwin, S.D. (eds) Advances in Artificial Intelligence. Canadian AI 2004. Lecture Notes in Computer Science 3060. Springer, Berlin, Heidelberg (2004) https://doi.org/10.1007/978-3-540-24840-8_26</Citation></Reference><Reference><Citation>Bielza, C. &amp; Larrañaga, P. Discrete Bayesian Network Classifiers: A Survey. ACM Computing Surveys 47(1), 1–43. https://doi.org/10.1145/2576868 (2014).</Citation><ArticleIdList><ArticleId IdType="doi">10.1145/2576868</ArticleId></ArticleIdList></Reference><Reference><Citation>Scutari, M. Learning Bayesian Networks with the bnlearn R package. Journal of Statistical Software 35(3), 1–22. https://doi.org/10.18637/jss.v035.i03 (2010).</Citation><ArticleIdList><ArticleId IdType="doi">10.18637/jss.v035.i03</ArticleId></ArticleIdList></Reference><Reference><Citation>Højsgaard, S. Graphical independence networks with the gRain package for R. Journal of Statistical Software 46(10), 1–26. https://doi.org/10.18637/jss.v046.i10 (2012).</Citation><ArticleIdList><ArticleId IdType="doi">10.18637/jss.v046.i10</ArticleId></ArticleIdList></Reference><Reference><Citation>Team, R Core R: A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria (2022) https://www.R-project.org/</Citation></Reference><Reference><Citation>Shapiro, S. S. &amp; Wilk, M. B. An analysis of variance test for normality (complete samples). Biometrika 52(3–4), 591–611. https://doi.org/10.2307/2333709 (1965).</Citation><ArticleIdList><ArticleId IdType="doi">10.2307/2333709</ArticleId></ArticleIdList></Reference><Reference><Citation>“Student” Gosset, W.S. The probable error of a mean. Biometrika 6(1), 1–25 (1908) https://doi.org/10.2307/3001968</Citation></Reference><Reference><Citation>Wilcoxon, F. Individual comparisons by ranking methods. Biometrics Bulletin 1(6), 80–83. https://doi.org/10.2307/3001968 (1945).</Citation><ArticleIdList><ArticleId IdType="doi">10.2307/3001968</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>